DUBLIN, Dec 16, 2021 / PRNewswire / – The report, “Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021-2026” has been added to the offering from ResearchAndMarkets.com.
Logo for research and markets
The global oligonucleotide synthesis market experienced strong growth in the period 2015-2020. Oligonucleotide synthesis is a chemical process in which short nucleic acid fragments are joined together to form the desired sequenced products. It can be customized by researchers depending on the application and its requirements. It is used as primers and probes in recombinant DNA technologies to develop monoclonal antibodies.
It is also used in biological, medical, forensic, and clinical applications for gene expression, cloning, molecular diagnostics, and genetic disease screening. In addition, it is gaining traction in multiple drug therapeutic practice with the introduction of automated reactor platforms that provide access to oligonucleotides at reasonable prices.
With the rise in coronavirus disease (COVID-19) cases and the urgency of possible treatment, new generations of oligonucleotide drugs, including mRNA and DNA vaccines, are being developed. In addition, the increasing incidence of cancer and other chronic diseases has led to an increasing need for novel diagnostics, influencing the need for oligonucleotide synthesis for the development of effective therapies and diagnostic methods. The growing geriatric population and the demand for personalized medicines are also supporting market growth.
In addition, with advances in purification and quality control technologies, the overall cost of oligonucleotide techniques can be reduced while quality and yield are significantly increased. This encourages the use of oligonucleotide synthesis in a number of available modifications. That said, several oligonucleotide-based therapies are in different stages of clinical trials. It is expected that this will drive demand for oligonucleotide synthesis for the treatment of viral infections, rare genetic disorders, and neuromuscular conditions. Looking ahead, the publisher expects the global oligonucleotide synthesis market to grow at a CAGR of 12.7% in the forecast period (2021-2026).
The story goes on
Competitive landscape:
The industry’s competitive landscape was also examined along with the profiles of key players including Agilent Technologies Inc., Biolegio BV, Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec SA ( Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc.
Key questions answered in this report:
-
How has the global market for oligonucleotide synthesis developed so far and how will it develop in the coming years?
-
What is the impact of COVID-19 on the Global Oligonucleotide Synthesis Market?
-
What are the main regional markets?
-
What is the market split based on the product?
-
What is the market split based on the application?
-
What is the market split based on end use?
-
What are the different stages of the industry’s value chain?
-
What are the main driving factors and challenges in the industry?
-
How is the global oligonucleotide synthesis market structured and who are the key players?
-
How high is the competition in the industry?
Key topics covered:
1 Introduction
2 Scope and methodology
3 Summary
4 Introduction
4.1 Overview
4.2 Major industry trends
5 Global Oligonucleotide Synthesis Market
5.1 Market overview
5.2 Market performance
5.3 Effects of COVID-19
5.4 Market forecast
6 Market division by product
6.1 Synthesized oligonucleotide products
6.1.1 Market trends
6.1.2 Market forecast
6.2 reagents
6.2.1 Market trends
6.2.2 Market forecast
6.3 Equipment
6.3.1 Market trends
6.3.2 Market forecast
6.4 Services
6.4.1 Market trends
6.4.2 Market forecast
7 Market division by application
7.1 PCR primers
7.1.1 Market trends
7.1.2 Market forecast
7.2 PCR assays and panels
7.2.1 Market trends
7.2.2 Market forecast
7.3 sequencing
7.3.1 Market trends
7.3.2 Market forecast
7.4 DNA microarrays
7.4.1 Market trends
7.4.2 Market forecast
7.5 Fluorescence In Situ Hybridization (FISH)
7.5.1 Market trends
7.5.2 Market forecast
7.6 Antisense oligonucleotides
7.6.1 Market trends
7.6.2 Market forecast
7.7 Other
7.7.1 Market trends
7.7.2 Market forecast
8 Market split according to end use
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market trends
8.1.2 Market forecast
8.2 Hospital and diagnostic laboratories
8.2.1 Market trends
8.2.2 Market forecast
8.3 Academic Research Institutes
8.3.1 Market trends
8.3.2 Market forecast
9 Market breakdown by region
10 SWOT analysis
11 Value chain analysis
12 Carriers – Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
14.1 Market structure
14.2 Key Players
14.3 Profiles of the main actors
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company overview
14.3.1.2 Product portfolio
14.3.1.3 Finances
14.3.1.4 SWOT analysis
14.3.2 Biolegio BV
14.3.2.1 Company overview
14.3.2.2 Product portfolio
14.3.3 Biosynthesis Inc
14.3.3.1 Company overview
14.3.3.2 Product portfolio
14.3.4 Eurofins Genomics
14.3.4.1 Company overview
14.3.4.2 Product portfolio
14.3.5 GenScript
14.3.5.1 Company overview
14.3.5.2 Product portfolio
14.3.6 Horizon Discovery Ltd
14.3.6.1 Company overview
14.3.6.2 Product portfolio
14.3.7 Integrated DNA Technologies Inc (Danaher Corporation)
14.3.7.1 Company overview
14.3.7.2 Product portfolio
14.3.8 Kaneka Eurogentec SA (Kaneka Corporation)
14.3.8.1 Company overview
14.3.8.2 Product portfolio
14.3.9 LGC Limited
14.3.9.1 Company overview
14.3.9.2 Product portfolio
14.3.10 Nitto Denko Avecia Inc (Nitto Denko Corporation)
14.3.10.1 Company overview
14.3.10.2 Product portfolio
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company overview
14.3.11.2 Product portfolio
14.3.11.3 Finances
14.3.11.4 SWOT analysis
Please visit https://www.researchandmarkets.com/r/9u2jk1 for more information on this report
Media contact:
Research and Markets
Laura wood, Senior manager
[email protected]
For EST office hours, call + 1-917-300-0470. on
For US / CAN toll free call + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900. on
US Fax: 646-607-1904
Fax (outside the US): + 353-1-481-1716
Cision
View original content: https://www.prnewswire.com/news-releases/outlook-on-the-oligonucleotide-synthesis-global-market-to-2026—by-product-application-end-use-and- region -301446294.html
SOURCE Research and Markets
Comments are closed.